Where Black Diamond Therapeutic Stands With Analysts
Portfolio Pulse from Benzinga Insights
Analysts have provided various ratings for Black Diamond Therapeutic (NASDAQ:BDTX) within the last quarter, with an average price target of $7.83, implying an upside from the current price of $4.85. The average price target has increased by 213.2% over the past month.
July 14, 2023 | 9:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts' average price target for Black Diamond Therapeutic (NASDAQ:BDTX) suggests a potential upside, which could positively impact the stock price.
The average price target set by analysts is significantly higher than the current price of Black Diamond Therapeutic's stock. This suggests that they believe the stock has potential for growth, which could lead to an increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100